Ixazomib-impurities | Pharmaffiliates

ixazomib and its Impurities

Ixazomib is used in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in adults after at least one prior therapy. It is taken by mouth in form of capsules. Reference standards of Ixazomib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 3 results for ixazomib Impurities
PA 09 55000

Ixazomib - API

Ixazomib


  • Catalogue No.:PA 09 55000

  • CAS :

    1072833-77-2

  • Molecular Formula : C14H19BCl2N2O4

  • Molecular Weight : 361.03

PA 09 55510

Ixazomib Citrate

Ixazomib Citrate


  • Catalogue No.:PA 09 55510

  • CAS :

    1239908-20-3

  • Molecular Formula : C20H23BCl2N2O9

  • Molecular Weight : 517.12

PA 09 0551000

4-(Carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic Acid

4-(Carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic Acid


  • Catalogue No.:PA 09 0551000

  • CAS :

    1201902-80-8

  • Molecular Formula : C20H23BCl2N2O9

  • Molecular Weight : 517.12